Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2023-07-03 00:00:00 ET · period of report 2023-06-29 · accession 0001209191-23-040654 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-03 | 2023-06-29+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.61 | +40.4K | 546.8K | +8% | +$24.6K |
| DM | 2023-07-03 | 2023-06-29+ | TYRA | Bensen Daniel | COO | S - Sale+OE | $16.70 | -40.4K | 528.0K | -7% | -$674.1K |
| DM | 2023-07-03 | 2023-06-29+ | TYRA | Bensen Daniel | COO | M - OptEx | $0.00 | -40.4K | 146.2K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-03 | M | A | 4,265 | $0.61 | 532,246 | D | — | — | |
| 2 | Common | Common Stock | 2023-07-03 | S | D | 3,865 | $16.30 | 528,381 | D | — | — | (F4) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16 to $17. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 3 | Common | Common Stock | 2023-07-03 | S | D | 400 | $17.04 | 527,981 | D | — | — | (F5) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.02 to $17.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 4 | Common | Common Stock | 2023-06-29 | M | A | 17,281 | $0.61 | 545,262 | D | — | — | |
| 5 | Common | Common Stock | 2023-06-29 | S | D | 17,281 | $16.49 | 527,981 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.13 to $17.09. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 6 | Common | Common Stock | 2023-06-30 | M | A | 18,819 | $0.61 | 546,800 | D | — | — | |
| 7 | Common | Common Stock | 2023-06-30 | S | D | 18,819 | $16.97 | 527,981 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.45 to $17.14. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-07-03 | M | D | 4,265 | $0.00 | 141,913 | D | $0.61 · — to 2030-01-26 | 4,265 Common Stock | (F6) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-06-29 | M | D | 17,281 | $0.00 | 164,997 | D | $0.61 · — to 2030-01-26 | 17,281 Common Stock | (F6) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |
| 10 | Derivative | Stock Option (Right to Buy) | 2023-06-30 | M | D | 18,819 | $0.00 | 146,178 | D | $0.61 · — to 2030-01-26 | 18,819 Common Stock | (F6) 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. |